跳至主要内容
临床试验/EUCTR2016-000211-33-GB
EUCTR2016-000211-33-GB进行中(未招募)1 期

Dose Effect Relationship of a Single Dose of Rituximab on the Kinetics of B Lymphocytes in Patients with Acute ST-Segment Myocardial Infarction - RITA-MI

Papworth Hospital NHS Foundation Trust0 个研究点目标入组 24 人开始时间: 2016年8月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Age 18-75 years old
  • 2. Acute anterior STEMI and successful primary percutaneous coronary intervention (PCI) with stent inplantation in the culpirt lesion during the first 24hrs after onset of symptoms
  • 3. Provision of written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 16
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 8

排除标准

  • 1. Previous history of STEMI
  • 2. Cardiogenic shock (systolic blood pressure <80mmHg; unresponsive to fluids, or necessitating catecholamines) electrical instability or severe congestive heart failure
  • 3. corrected QT interval >500msecs using Bazett's formula
  • 4. Hematologic abnormalities (hemoglobin <10g/dL or hematocrit <30%, platelet cell count of <100x10(3)/uL, white blood cell count <4x10(3)/uL)
  • 5. Renal failure (estimated GFR by the MDRD formula <45ml/min/1.73m2)
  • 6. Known hepatic failure or abnormal liver function tests at baseline (ALT>2xULN)
  • 7. Active or recurrent hepatitis (type B)
  • 8. Known HIV infection
  • 9. Current or previous tuberculosis (CXR)
  • 10. Current infections
  • 11. Presence or history in the previous five years of an ongoing cancer, except in situe cancer of the cervix or basal cell carcinoma
  • 12. Any oral or intravenous immunosuppressive treatment (other than concomitant 100mg methylprednisolone), disease modifying drugs or other immue modulatory monoclonal antibodies
  • 13. Allergy to rituximab or one of its excipients
  • 14. Expected need for vaccination with a live attenuated vaccine during the study including incomplete vaccination courses
  • 15. Known or suspected preganacy at screening or lactating women
  • 16. Women of childbearing age unless confirmed by direct questioning that they are reproductively sterile or post menopausal
  • 17. Participation in other clinical trials
  • 18. Inability to comply with study procedures

研究者

相似试验

Assessing the blood effects of the immunosuppressant... | 临床试验